The DOI matches its Crossref record; 239 of the 239 references it cites were found in a registry or an index.
Inflammatory bone loss: pathogenesis and therapeutic intervention
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961 · cited 1×
“AP1 regulates the differentiation and proliferation, as well as apoptosis, of various cell type”
BackgroundTakayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Bliuc, D. (2009) · JAMA · doi:10.1001/jama.2009.50 · Cited by 1,699
Furie, R., Petri, M., Zamani, O., Cervera, R., Wallace, D. J., Tegzová, D., Sanchez-Guerrero, J., Schwarting, A., Merrill, J. T., Chatham, W. W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30613 · Cited by 1,683
Ravetch, J. V., & Bolland, S. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.275 · Cited by 1,657
Tian, E., Zhan, F., Walker, R., Rasmussen, E., Ma, Y., Barlogie, B., & Shaughnessy, J. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030847 · Cited by 1,503
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., & O'Connor, J. V. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1433 · Cited by 1,472
Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440 · cited 1×
“In addition, under just permissive (subosteoclastogenic) concentrations of RANKL, TNF can induce the differentiation of monocytes and macrophages to the stage of preosteoclast”
BackgroundSclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366 · cited 1×
“Sclerostin represents another inhibitor of osteoblast activation by interfering with the WNT signalling pathway but also by binding to and antagonizing BMP”
BackgroundTUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., & Boldin, M. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.331 · Cited by 1,312
Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.275 · Cited by 1,304
Dickkopf-1 is a master regulator of joint remodeling
Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1538 · Cited by 1,298
Self-citationc-Fos: a Key Regulator of Osteoclast-Macrophage Lineage Determination and Bone Remodeling
Grigoriadis, A. E., Wang, Z.-Q., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A., & Wagner, E. F. (1994) · Science · doi:10.1126/science.7939685 · Cited by 1,260
Denosumab in postmenopausal women with low bone mineral density.
McClung, M. R., Lewiecki, E. M., Cohen, S. B., Bolognese, M. A., Woodson, G. C., Moffett, A. H., Peacock, M., Miller, P. D., Lederman, S. N., Chesnut, C. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044459 · Cited by 1,228
Towards an integrated view of Wnt signaling in development
van Amerongen, R., & Nusse, R. (2009) · Development · doi:10.1242/dev.033910 · Cited by 1,175
Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., & Riggs, B. L. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.2 · Cited by 1,173
Canonical WNT Signaling Promotes Osteogenesis by Directly Stimulating Runx2 Gene Expression
Gaur, T., Lengner, C. J., Hovhannisyan, H., Bhat, R. A., Bodine, P. V. N., Komm, B. S., Javed, A., van Wijnen, A. J., Stein, J. L., Stein, G. S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500608200 · Cited by 1,170
Interleukin-1 and the Pathogenesis of the Acute-Phase Response
Epstein, F. H., & Dinarello, C. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411293112205 · Cited by 1,146
Bisphosphonates: The first 40years
Russell, R. G. G. (2011) · Bone · doi:10.1016/j.bone.2011.04.022 · Cited by 1,124
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
Winkler, D. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg599 · Cited by 1,112
Exercise for preventing and treating osteoporosis in postmenopausal women
Howe, T. E., Shea, B., Dawson, L. J., Downie, F., Murray, A., Ross, C., Harbour, R. T., Caldwell, L. M., & Creed, G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000333.pub2 · Cited by 1,083
Osteocytes, mechanosensing and Wnt signaling
Bonewald, L. F., & Johnson, M. L. (2008) · Bone · doi:10.1016/j.bone.2007.12.224 · Cited by 1,076
Skeletal remodeling in health and disease
Zaidi, M. (2007) · Nature Medicine · doi:10.1038/nm1593 · Cited by 1,069
Tumor necrosis factor: a pleiotropic cytokine and therapuetic target
Tracey, M. D., & Cerami, P. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.491 · Cited by 1,063
Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling
Mao, B., Wu, W., Davidson, G., Marhold, J., Li, M., Mechler, B. M., Delius, H., Hoppe, D., Stannek, P., Walter, C., et al. (2002) · Nature · doi:10.1038/nature756 · Cited by 1,038
Wiktor-Jedrzejczak, W., Bartocci, A., Ferrante, A. W., Ahmed-Ansari, A., Sell, K. W., Pollard, J. W., & Stanley, E. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4828 · Cited by 1,031
New therapies for treatment of rheumatoid arthritis
Smolen, J. S., Aletaha, D., Koeller, M., Weisman, M. H., & Emery, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60784-3 · Cited by 995
Self-citationLi, X., Ominsky, M. S., Niu, Q.-T., Sun, N., Daugherty, B., D'Agostin, D., Kurahara, C., Gao, Y., Cao, J., Gong, J., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080216 · Cited by 936
Therapeutic strategies for rheumatoid arthritis
Smolen, J. S., & Steiner, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1109 · Cited by 911
Self-citationComparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Griffiths, C. E. M., Strober, B. E., van de Kerkhof, P., Ho, V., Fidelus-Gort, R., Yeilding, N., Guzzo, C., Xia, Y., Zhou, B., Li, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0810652 · Cited by 859
Mortality after osteoporotic fractures
Johnell, O., Kanis, J. A., Odén, A., Sernbo, I., Redlund-Johnell, I., Petterson, C., De Laet, C., & Jönsson, B. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1490-4 · Cited by 848
IL-6: From its discovery to clinical applications
Kishimoto, T. (2010) · International Immunology · doi:10.1093/intimm/dxq030 · Cited by 846
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis
Koga, T., Inui, M., Inoue, K., Kim, S., Suematsu, A., Kobayashi, E., Iwata, T., Ohnishi, H., Matozaki, T., Kodama, T., et al. (2004) · Nature · doi:10.1038/nature02444 · Cited by 828
Cellular mechanisms of bone remodeling
Eriksen, E. F. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9153-1 · Cited by 821
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
Chen, D., Frezza, M., Schmitt, S., Kanwar, J., & P. Dou, Q. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794519752 · Cited by 795
Li, X., Ominsky, M. S., Warmington, K. S., Morony, S., Gong, J., Cao, J., Gao, Y., Shalhoub, V., Tipton, B., Haldankar, R., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081206 · Cited by 784
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., & Costantini, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06368.x · Cited by 749
IL-6-Induced Homodimerization of gp130 and Associated Activation of a Tyrosine Kinase
Murakami, M., Hibi, M., Nakagawa, N., Nakagawa, T., Yasukawa, K., Yamanishi, K., Taga, T., & Kishimoto, T. (1993) · Science · doi:10.1126/science.8511589 · Cited by 724
Mammalian target of rapamycin: a central node of complex signaling cascades.
Dobashi, Y., Watanabe, Y., Miwa, C., Suzuki, S., & Koyama, S. (2011) · PubMed · Cited by 723
Rose-John, S., Scheller, J., Elson, G., & Jones, S. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105674 · Cited by 647
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
Generalised bone loss in patients with early rheumatoid arthritis.
GOUGH, A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91049-9 · Cited by 630
Müller‐Ladner, U., Kriegsmann, J., Franklin, B. N., Matsumoto, S., Geiler, T., Gay, R. E., & Gay, S. (1996) · Europe PMC (PubMed Central) · Cited by 606
Murshed, M., Harmey, D., Millán, J. L., McKee, M. D., & Karsenty, G. (2005) · Genes & Development · doi:10.1101/gad.1276205 · Cited by 601
LONG-TERM OUTCOME OF TREATING RHEUMATOID ARTHRITIS: RESULTS AFTER 20 YEARS
Scott, D. L., Coulton, B. L., Symmons, D. P. M., & Popert, A. J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91672-2 · Cited by 594
Cohen, S. B., Dore, R. K., Lane, N. E., Ory, P. A., Peterfy, C. G., Sharp, J. T., van der Heijde, D., Zhou, L., Tsuji, W., Newmark, R., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23417 · Cited by 576
Kawai, T., Matsuyama, T., Hosokawa, Y., Makihira, S., Seki, M., Karimbux, N. Y., Goncalves, R. B., Valverde, P., Dibart, S., Li, Y.-P., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.060180 · Cited by 565
Kotake, S., Sato, K., Kim, K. J., Takahashi, N., Udagawa, N., Nakamura, I., Yamaguchi, A., Kishimoto, T., Suda, T., & Kashiwazaki, S. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110113 · Cited by 545
Long-Term Use of Bisphosphonates in Osteoporosis
Watts, N. B., & Diab, D. L. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1947 · Cited by 542
Franceschi, R. T., & Xiao, G. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10369 · Cited by 541
Osteoclasts are essential for TNF-α–mediated joint destruction
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15582 · Cited by 531
Self-citationGravallese, E. M., Harada, Y., Wang, J. T., Gorn, A. H., Thornhill, T. S., & Goldring, S. R. (1998) · Europe PMC (PubMed Central) · Cited by 516
Roggia, C., Gao, Y., Cenci, S., Weitzmann, M. N., Toraldo, G., Isaia, G., & Pacifici, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251534698 · Cited by 513
Sims, N. A., & Gooi, J. H. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.07.016 · Cited by 513
The paradigm of IL-6: from basic science to medicine.
Naka, T., Nishimoto, N., & Kishimoto, T. (2002) · Arthritis Research · doi:10.1186/ar565 · Cited by 498
Zhang, Y.-H., Heulsmann, A., Tondravi, M. M., Mukherjee, A., & Abu-Amer, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008198200 · Cited by 498
Teng, Y.-T. A., Nguyen, H., Gao, X., Kong, Y.-Y., Gorczynski, R. M., Singh, B., Ellen, R. P., & Penninger, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10763 · Cited by 493
NFAT and Osterix cooperatively regulate bone formation
Koga, T., Matsui, Y., Asagiri, M., Kodama, T., de Crombrugghe, B., Nakashima, K., & Takayanagi, H. (2005) · Nature Medicine · doi:10.1038/nm1270 · Cited by 490
Inhibition of osteoblastic bone formation by nuclear factor-κB
Chang, J., Wang, Z., Tang, E., Fan, Z., McCauley, L., Franceschi, R., Guan, K., Krebsbach, P. H., & Wang, C.-Y. (2009) · Nature Medicine · doi:10.1038/nm.1954 · Cited by 481
Mundy, G. R. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00353.x · Cited by 478
Osteoclasts are essential for TNF-α-mediated joint destruction.
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215582 · Cited by 474
Self-citationNetworks and hubs for the transcriptional control of osteoblastogenesis
Lian, J. B., Stein, G. S., Javed, A., van Wijnen, A. J., Stein, J. L., Montecino, M., Hassan, M. Q., Gaur, T., Lengner, C. J., & Young, D. W. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9001-5 · Cited by 468
Mócsai, A., Humphrey, M. B., Van Ziffle, J. A. G., Hu, Y., Burghardt, A., Spusta, S. C., Majumdar, S., Lanier, L. L., Lowell, C. A., & Nakamura, M. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401602101 · Cited by 463
Smolen, J. S., Han, C., Bala, M., Maini, R. N., Kalden, J. R., van der Heijde, D., Breedveld, F. C., Furst, D. E., Lipsky, P. E., & ATTRACT Study Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.20982 · Cited by 462
Self-citationTNF: A master switch for inflammation to cancer
Sethi, G. (2008) · Frontiers in Bioscience · doi:10.2741/3066 · Cited by 458
Kim, J. E., & Chen, J. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2748 · Cited by 454
Gilbert, L., He, X., Farmer, P., Rubin, J., Drissi, H., van Wijnen, A. J., Lian, J. B., Stein, G. S., & Nanes, M. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106339200 · Cited by 443
Osteocytes as Dynamic Multifunctional Cells
BONEWALD, L. F. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.018 · Cited by 417
Hoes, J. N., Jacobs, J. W. G., Boers, M., Boumpas, D., Buttgereit, F., Caeyers, N., Choy, E. H., Cutolo, M., Da Silva, J. A. P., Esselens, G., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.072157 · Cited by 411
Kremer, J. M., Blanco, R., Brzosko, M., Burgos-Vargas, R., Halland, A.-M., Vernon, E., Ambs, P., & Fleischmann, R. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30158 · Cited by 409
Nam, J. L., Winthrop, K. L., van Vollenhoven, R. F., Pavelka, K., Valesini, G., Hensor, E. M. A., Worthy, G., Landewé, R., Smolen, J. S., Emery, P., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.126573 · Cited by 406
Self-citationMundy, G. R. (2007) · Nutrition Reviews · doi:10.1301/nr.2007.dec.s147-s151 · Cited by 406
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
Fulciniti, M., Tassone, P., Hideshima, T., Vallet, S., Nanjappa, P., Ettenberg, S. A., Shen, Z., Patel, N., Tai, Y.-T., Chauhan, D., et al. (2009) · Blood · doi:10.1182/blood-2008-11-191577 · Cited by 399
Interleukin-11: a new cytokine critical for osteoclast development.
Girasole, G., Passeri, G., Jilka, R. L., & Manolagas, S. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117130 · Cited by 399
miR-29 Modulates Wnt Signaling in Human Osteoblasts through a Positive Feedback Loop
Kapinas, K., Kessler, C., Ricks, T., Gronowicz, G., & Delany, A. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116137 · Cited by 396
Glucocorticoids suppress bone formation via the osteoclast.
Kim, H.-J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28084 · Cited by 384 · cited 1×
“Importantly, although these agents are highly effective at reducing or blocking the inflammatory process, they are also major mediators of osteoporosis as they heavily interfere with bone remodellin”
BackgroundAn Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis
Weinblatt, M. E., Kavanaugh, A., Genovese, M. C., Musser, T. K., Grossbard, E. B., & Magilavy, D. B. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000500 · Cited by 381
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation
Bezooijen, R. L. V., Dijke, P. T., Papapoulos, S. E., & G.M. Löwik, C. W. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.02.005 · Cited by 367
Guerne, P. A., Carson, D. A., & Lotz, M. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.2.499 · Cited by 361
Targeting the PI3K/Akt/mTOR Pathway - Beyond Rapalogs
Markman, B., Dienstmann, R., & Tabernero, J. (2010) · Oncotarget · doi:10.18632/oncotarget.188 · Cited by 355
M-CSF, TNFα and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase
Glantschnig, H., Fisher, J. E., Wesolowski, G., Rodan, G. A., & Reszka, A. A. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401285 · Cited by 350
Westhovens, R., Robles, M., Ximenes, A. C., Nayiager, S., Wollenhaupt, J., Durez, P., Gomez-Reino, J., Grassi, W., Haraoui, B., Shergy, W., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101121 · Cited by 348
Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities
Delaissé, J., Andersen, T. L., Engsig, M. T., Henriksen, K., Troen, T., & Blavier, L. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10374 · Cited by 341
Sokolove, J., Zhao, X., Chandra, P. E., & Robinson, W. H. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30081 · Cited by 340
Role of Members of the Wnt Gene Family in Human Hematopoiesis
Van Den Berg, D. J., Sharma, A. K., Bruno, E., & Hoffman, R. (1998) · Blood · doi:10.1182/blood.v92.9.3189 · Cited by 339
Bone morphogenetic proteins and their antagonists
Gazzerro, E., & Canalis, E. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9000-6 · Cited by 338
Joint Erosions and Patients with Early Rheumatoid Arthritis
van der Heijde, D. M. F. M. (1995) · Rheumatology · doi:10.1093/rheumatology/xxxiv.suppl_2.74 · Cited by 334
Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro
Garrett, I. R., Chen, D., Gutierrez, G., Zhao, M., Escobedo, A., Rossini, G., Harris, S. E., Gallwitz, W., Kim, K. B., Hu, S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16198 · Cited by 328
Kaneki, H., Guo, R., Chen, D., Yao, Z., Schwarz, E. M., Zhang, Y. E., Boyce, B. F., & Xing, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509430200 · Cited by 310
Dental infections and coronary atherosclerosis
Mattila, K. J., Valle, M. S., Nieminen, M. S., Valtonen, V. V., & Hietaniemi, K. L. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90263-t · Cited by 308
Tak, P. P., Rigby, W. F., Rubbert-Roth, A., Peterfy, C. G., van Vollenhoven, R. F., Stohl, W., Hessey, E., Chen, A., Tyrrell, H., & Shaw, T. M. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.137703 · Cited by 307
Targeting inflammation by modulating the Jun/AP-1 pathway
Schonthaler, H. B., Guinea-Viniegra, J., & Wagner, E. F. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.140533 · Cited by 302
Walker, E. C., McGregor, N. E., Poulton, I. J., Solano, M., Pompolo, S., Fernandes, T. J., Constable, M. J., Nicholson, G. C., Zhang, J.-G., Nicola, N. A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40568 · Cited by 300
Partsch, G., Steiner, G. E., Leeb, B. F., Dunky, A., Bröll, H., & Smolen, J. S. (1997) · PubMed · Cited by 297
Self-citationDe Benedetti, F., Rucci, N., Del Fattore, A., Peruzzi, B., Paro, R., Longo, M., Vivarelli, M., Muratori, F., Berni, S., Ballanti, P., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22175 · Cited by 296
Regulation of the Acute Phase Response by Cytokines
Kushner, I. (1993) · Perspectives in Biology and Medicine · doi:10.1353/pbm.1993.0004 · Cited by 292
Abu-Amer, Y., Ross, F. P., Edwards, J., & Teitelbaum, S. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119679 · Cited by 289
Zou, W., Kitaura, H., Reeve, J., Long, F., Tybulewicz, V. L. J., Shattil, S. J., Ginsberg, M. H., Ross, F. P., & Teitelbaum, S. L. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611083 · Cited by 288
Redlich, K., Hayer, S., Maier, A., Dunstan, C. R., Tohidast‐Akrad, M., Lang, S., Türk, B., Pietschmann, P., Woloszczuk, W., Haralambous, S., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10097 · Cited by 285
Self-citationWnt signaling and osteoblastogenesis
Bodine, P. V. N., & Komm, B. S. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9002-4 · Cited by 285
A microRNA expression signature of osteoclastogenesis
Sugatani, T., Vacher, J., & Hruska, K. A. (2011) · Blood · doi:10.1182/blood-2010-10-311415 · Cited by 275
Consensus on a core set of domains for psoriatic arthritis.
Gladman, D. D., Mease, P. J., Strand, V., Healy, P. J., Helliwell, P., FitzGerald, O., Gottlieb, A. B., Krueger, G. G., Nash, P. T., Ritchlin, C. T., et al. (2007) · PubMed · Cited by 274
Kwack, M. H., Sung, Y. K., Chung, E. J., Im, S. U., Ahn, J. S., Kim, M. K., & Kim, J. C. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700999 · Cited by 274
Fedi, P., Bafico, A., Soria, A. N., Burgess, W. H., Miki, T., Bottaro, D. P., Kraus, M. H., & Aaronson, S. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19465 · Cited by 274
Wong, P. K. K., Quinn, J. M. W., Sims, N. A., van Nieuwenhuijze, A., Campbell, I. K., & Wicks, I. P. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21537 · Cited by 270
Osteoporosis in Inflammatory Bowel Disease
Ali, T., Lam, D., Bronze, M. S., & Humphrey, M. B. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.01.022 · Cited by 266
Ominsky, M. S., Li, C., Li, X., Tan, H. L., Lee, E., Barrero, M., Asuncion, F. J., Dwyer, D., Han, C.-Y., Vlasseros, F., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.307 · Cited by 264
Zhang, Y., Lin, J.-X., & Vilček, J. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.7.3818-3823.1990 · Cited by 263
Perlstein, R. S., Whitnall, M. H., Abrams, J. S., Mougey, E. H., & Neta, R. (1993) · Endocrinology · doi:10.1210/en.132.3.946 · Cited by 257
Essential role of microRNA‐155 in the pathogenesis of autoimmune arthritis in mice
Blüml, S., Bonelli, M., Niederreiter, B., Puchner, A., Mayr, G., Hayer, S., Koenders, M. I., van den Berg, W. B., Smolen, J., & Redlich, K. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30281 · Cited by 253
Self-citationKim, M. S., Day, C. J., & Morrison, N. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412713200 · Cited by 251
Andus, T., Geiger, T., Hirano, T., Kishimoto, T., & Heinrich, P. C. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180513 · Cited by 250
Eisman, J. A., Bone, H. G., Hosking, D. J., McClung, M. R., Reid, I. R., Rizzoli, R., Resch, H., Verbruggen, N., Hustad, C. M., DaSilva, C., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.212 · Cited by 244
Smolen, J. S., Han, C., van der Heijde, D. M. F. M., Emery, P., Bathon, J. M., Keystone, E., Maini, R. N., Kalden, J. R., Aletaha, D., Baker, D., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.090019 · Cited by 236
Self-citationCharacterization of the Structural Features and Interactions of Sclerostin
Veverka, V., Henry, A. J., Slocombe, P. M., Ventom, A., Mulloy, B., Muskett, F. W., Muzylak, M., Greenslade, K., Moore, A., Zhang, L., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807994200 · Cited by 233
Okamoto, H., Yamamura, M., Morita, Y., Harada, S., Makino, H., & Ota, Z. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400614 · Cited by 233
Risk Factors for Total Tooth Loss in the United States; Longitudinal Analysis of National Data
Eklund, S. A., & Burt, B. A. (1994) · Journal of Public Health Dentistry · doi:10.1111/j.1752-7325.1994.tb01173.x · Cited by 232
Vignery, A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051123 · Cited by 232
Eggelmeijer, F., Papapoulos, S. E., van Paassen, H. C., Dijkmans, B. A. C., Valkema, R., Westedt, M. L., Landman, J., Pauwels, E. K. J., & Breedveld, F. C. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390307 · Cited by 227
Ding, J., Ghali, O., Lencel, P., Broux, O., Chauveau, C., Devedjian, J. C., Hardouin, P., & Magne, D. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.01.013 · Cited by 221
Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice
Sasai, M., Saeki, Y., Ohshima, S., Nishioka, K., Mima, T., Tanaka, T., Katada, Y., Yoshizaki, K., Suemura, M., & Kishimoto, T. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199908)42:8<1635::aid-anr11>3.0.co;2-q · Cited by 208
Heiland, G. R., Zwerina, K., Baum, W., Kireva, T., Distler, J. H., Grisanti, M., Asuncion, F., Li, X., Ominsky, M., Richards, W., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.132852 · Cited by 208
Binder, N. B., Niederreiter, B., Hoffmann, O., Stange, R., Pap, T., Stulnig, T. M., Mack, M., Erben, R. G., Smolen, J. S., & Redlich, K. (2009) · Nature Medicine · doi:10.1038/nm.1945 · Cited by 206
Self-citationBortezomib inhibits human osteoclastogenesis
von Metzler, I., Krebbel, H., Hecht, M., Manz, R. A., Fleissner, C., Mieth, M., Kaiser, M., Jakob, C., Sterz, J., Kleeberg, L., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404806 · Cited by 197
Impaired Micro-RNA Pathways Diminish Osteoclast Differentiation and Function
Sugatani, T., & Hruska, K. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805777200 · Cited by 196
Aletaha, D., Funovits, J., & Smolen, J. S. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.138693 · Cited by 194
Self-citationDore, R. K., Cohen, S. B., Lane, N. E., Palmer, W., Shergy, W., Zhou, L., Wang, H., Tsuji, W., & Newmark, R. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.112920 · Cited by 194
Zhang, Y. H., Lin, J. X., & Vilcek, J. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.7.3818 · Cited by 190
Machold, K. P., Stamm, T., Eberl, G., Nell, V. P. K., Dunky, A., Uffmann, M., & Smolen, J. S. (2002) · PubMed · Cited by 186
Self-citationMicroRNA biogenesis and regulation of bone remodeling
Kapinas, K., & Delany, A. M. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3325 · Cited by 186
Vincent, C., Findlay, D. M., Welldon, K. J., Wijenayaka, A. R., Zheng, T. S., Haynes, D. R., Fazzalari, N. L., Evdokiou, A., & Atkins, G. J. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090305 · Cited by 180
The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat
van Gool, J., van Vugt, H., Helle, M., & Aarden, L. A. (1990) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(90)90034-n · Cited by 179
Cejka, D., Hayer, S., Niederreiter, B., Sieghart, W., Fuereder, T., Zwerina, J., & Schett, G. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27504 · Cited by 174
Towards quantitative 3D imaging of the osteocyte lacuno-canalicular network
Schneider, P., Meier, M., Wepf, R., & Müller, R. (2010) · Bone · doi:10.1016/j.bone.2010.07.026 · Cited by 172
Lange, U., Teichmann, J., Müller-Ladner, U., & Strunk, J. (2005) · Rheumatology · doi:10.1093/rheumatology/kei082 · Cited by 171
SHINGU, M., NAGAI, Y., ISAYAMA, T., NAONO, T., NOBUNAGA, M., & NAGAI, Y. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05992.x · Cited by 170
Primary hyperparathyroidism and the skeleton
Mosekilde, L. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03162.x · Cited by 167
van Vollenhoven, R. F., Kinnman, N., Vincent, E., Wax, S., & Bathon, J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30372 · Cited by 167
Schmidt, N., Gonzalez, E., Visekruna, A., Kühl, A. A., Loddenkemper, C., Mollenkopf, H., Kaufmann, S. H. E., Steinhoff, U., & Joeris, T. (2010) · Gut · doi:10.1136/gut.2009.203554 · Cited by 166
Qin, L., Qiu, P., Wang, L., Li, X., Swarthout, J. T., Soteropoulos, P., Tolias, P., & Partridge, N. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212226200 · Cited by 161
Novel functions for NFκB: inhibition of bone formation
Krum, S. A., Chang, J., Miranda-Carboni, G., & Wang, C.-Y. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.133 · Cited by 159
Hundorfean, G., Neurath, M. F., & Mudter, J. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21677 · Cited by 159
Boraiah, S., Paul, O., Hawkes, D. H., Wickham, M., & Lorich, D. G. (2009) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-009-1039-8 · Cited by 154
Jarrett, S. J., Conaghan, P. G., Sloan, V. S., Papanastasiou, P., Ortmann, C.-E., O’Connor, P., Grainger, A. J., & Emery, P. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21824 · Cited by 152
Human giant cell tumors of bone identification and characterization of cell types.
Goldring, S. R., Roelke, M. S., Petrison, K. K., & Bhan, A. K. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112838 · Cited by 152
Regulation of adult bone turnover by sex steroids
Frenkel, B., Hong, A., Baniwal, S. K., Coetzee, G. A., Ohlsson, C., Khalid, O. S., & Gabet, Y. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22159 · Cited by 151
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.
Schett, G., Redlich, K., Hayer, S., Zwerina, J., Bolon, B., Dunstan, C., Görtz, B., Schulz, A., Bergmeister, H., Kollias, G., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11150 · Cited by 150
Self-citationBianchi, M. L., & Bardella, M. T. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0624-0 · Cited by 147
Shimizu, S., Shiozawa, S., Shiozawa, K., Imura, S., & Fujita, T. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280105 · Cited by 145
Use of sirolimus (rapamycin) to treat refractory Crohn’s disease
Massey, D. C. O., Bredin, F., & Parkes, M. (2008) · Gut · doi:10.1136/gut.2008.157297 · Cited by 144
Rowan, A. D., Koshy, P. J. T., Shingleton, W. D., Degnan, B. A., Heath, J. K., Vernallis, A. B., Spaull, J. R., Life, P. F., Hudson, K., & Cawston, T. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1620::aid-art285>3.0.co;2-b · Cited by 143
Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun)
Wagner, E. F. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119396 · Cited by 142
TNF-α inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling
Mukai, T., Otsuka, F., Otani, H., Yamashita, M., Takasugi, K., Inagaki, K., Yamamura, M., & Makino, H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.099 · Cited by 138
Wan, Y. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.08.006 · Cited by 138
van der Heijde, D. M. F. M., Simon, L. S., Smolen, J. S., Strand, V., Sharp, J. T., Boers, M., Breedveld, F. C., Weisman, M. H., Weinblatt, M. E., Rau, R., et al. (2002) · Arthritis Care & Research · doi:10.1002/art.10181 · Cited by 138
Self-citationInterleukin-6 inhibits bone formation in vitro
Hughes, F. J., & Howells, G. L. (1993) · Bone and Mineral · doi:10.1016/s0169-6009(08)80117-1 · Cited by 137
Smolen, J. S., Ávila, J. C. M., & Aletaha, D. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200395 · Cited by 135
Self-citationRedlich, K., Görtz, B., Hayer, S., Zwerina, J., Doerr, N., Kostenuik, P., Bergmeister, H., Kollias, G., Steiner, G., Smolen, J. S., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63144-6 · Cited by 134
Self-citationCusick, T. E., Chen, C. M., Pennypacker, B. L., Pickarski, M., Kimmel, D. B., Scott, B. B., & Duong, L. T. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1477 · Cited by 134
Tumor necrosis factor-α inhibits pre-osteoblast differentiation through its type-1 receptor
Abbas, S., Zhang, Y.-H., Clohisy, J. C. F., & Abu‐Amer, Y. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00106-6 · Cited by 132
Paganelli, M., Albanese, C. V., Borrelli, O., Civitelli, F. S., Canitano, N., Viola, F., Passariello, R., & Cucchiara, S. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20039 · Cited by 130
Atacicept: targeting B cells in multiple sclerosis
Hartung, H., & Kieseier, B. C. (2010) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610371146 · Cited by 129
Taylor, P. C., Quattrocchi, E., Mallett, S. A., Kurrasch, R., Petersen, J. H., & Chang, D. J. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.151522 · Cited by 129
Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen‐induced arthritis
Sims, N. A., Green, J. R., Glatt, M., Schlicht, S., Martin, T. J., Gillespie, M. T., & Romas, E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20382 · Cited by 128
Gilbert, L. C., Rubin, J. E., & Nanes, M. S. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00534.2004 · Cited by 127
Devlin, R. D., Reddy, S. V., Savino, R., Ciliberto, G., & Roodman, G. D. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.3.393 · Cited by 126
GP130 cytokines and bone remodelling in health and disease
Sims, N. A., & Walsh, N. C. (2010) · BMB Reports · doi:10.5483/bmbrep.2010.43.8.513 · Cited by 124
Raisz, L. G., & Rodan, G. A. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00055-5 · Cited by 122
Ikejima, T., Okusawa, S., Ghezzi, P., van der Meer, J. W. M., & Dinarello, C. A. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.1.215 · Cited by 118
Gooi, J. H., Pompolo, S., Karsdal, M. A., Kulkarni, N. H., Kalajzic, I., McAhren, S. H. M., Han, B., Onyia, J. E., Ho, P. W. M., Gillespie, M. T., et al. (2010) · Bone · doi:10.1016/j.bone.2010.02.018 · Cited by 117
Therapeutic blockade of TNF in patients with SLE—Promising or crazy?
Aringer, M., & Smolen, J. S. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.001 · Cited by 117
Self-citationRachoń, D., Myśliwska, J. M., Suchecka-Rachoń, K., Więckiewicz, J., & Myśliwski, A. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1720387 · Cited by 117
Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma
Dam, T.-T. L., Harrison, S. L., Fink, H. A., Ramsdell, J., & Barrett-Connor, E. L. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1076-x · Cited by 115
Herrak, P., Görtz, B., Hayer, S., Redlich, K., Reiter, E., Gasser, J., Bergmeister, H., Kollias, G., Smolen, J. S., & Schett, G. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20384 · Cited by 110
Self-citationProteasome inhibitors abrogate osteoclast differentiation and osteoclast function
Zavrski, I., Krebbel, H., Wildemann, B., Heider, U., Kaiser, M., Possinger, K., & Sezer, O. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.098 · Cited by 105
Maintenance Infliximab Treatment Is Associated with Improved Bone Mineral Density in Crohn's Disease
Bernstein, M., Irwin, S. P., & Greenberg, G. R. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.50219.x · Cited by 104
Haugeberg, G., Conaghan, P. G., Quinn, M. A., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.106484 · Cited by 104
Betts, A. M., Clark, T. H., Yang, J., Treadway, J. L., Li, M., Giovanelli, M. A., Abdiche, Y. N., Stone, D. M., & Paralkar, V. M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.164129 · Cited by 103
Shead, E. F., HAWORTH, C. S., Barker, H. C., Bilton, D., & Compston, J. E. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.11.007 · Cited by 103
The Role of Exercise in the Treatment of Osteoporosis
Sinaki, M., Pfeifer, M. A., Preisinger, E., Itoi, E., Rizzoli, R., Boonen, S., Geusens, P., & Minne, H. W. (2010) · Current Osteoporosis Reports · doi:10.1007/s11914-010-0019-y · Cited by 100
Grabowski, P. (2009) · Endocrine development · doi:10.1159/000223687 · Cited by 96
Romero, G. G., Sneddon, W. B., Yang, Y., Wheeler, D., Blair, H., & Friedman, P. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.102970 · Cited by 93
Wnt Signaling Regulates Hemopoiesis Through Stromal Cells
Yamane, T., Kunisada, T., Tsukamoto, H., Yamazaki, H., Niwa, H., Takada, S., & Hayashi, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.765 · Cited by 92
Colucci, S. C., Brunetti, G., Cantatore, F. P., Oranger, A., Mori, G., Quarta, L., Cirulli, N., Mancini, L., Corrado, A., Grassi, F. R., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2153 · Cited by 91
Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs
Yang, M., & Mattes, J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.08.004 · Cited by 88
IL-1 Stimulation of Osteoclast Survival through the PI 3-Kinase/Akt and ERK Pathways
Lee, Z. H., Lee, S. E., Kim, C.-W., Lee, S.-H., Kim, S. W., Kwack, K., Walsh, K. X., & Kim, H.-H. (2002) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003071 · Cited by 87
Westenfeld, R., Schlieper, G., Wöltje, M., Gawlik, A., Brandenburg, V. M., Rutkowski, P., Floege, J., Jahnen‐Dechent, W., & Ketteler, M. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr214 · Cited by 83
Cited by
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915
Smolen, J. S., Aletaha, D., Barton, A., Burmester, G. R., Emery, P., Firestein, G. S., Kavanaugh, A., McInnes, I. B., Solomon, D. H., Strand, V., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.1 · Cited by 2,445
Self-citationDiagnosis and Management of Rheumatoid Arthritis: A Review
Aletaha, D., & Smolen, J. S. (2018) · JAMA · doi:10.1001/jama.2018.13103 · Cited by 2,313
Self-citationUpdate on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Lin, Y.-J., Anzaghe, M., & Schülke, S. (2020) · Cells · doi:10.3390/cells9040880 · Cited by 932
Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes
Nygaard, G., & Firestein, G. S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0413-5 · Cited by 928
Metadata
- Authors
- Redlich, K., & Smolen, J. S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-03
- Volume
- 11
- Issue
- 3
- Pages
- 234-250
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2039057018
- Cited by
- 830
- References
- 239
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.